On Tuesday, November 10, 2020, the Company, Oncternal Therapeutics, Inc., ONCT stock construct a change of 8.82 percent (Gain) in a total of its share price and having its trading value $5.55, which belongs to Healthcare sector and Biotechnology industry. The companys Market capitalization was $106.34M with the total Outstanding Shares of 16.24M.
P/S, P/E, P/B & P/C values of (NASDAQ: ONCT):
Oncternal Therapeutics, Inc. institutional ownership is standing at 13.6 percent, while insider ownership is 5.7 percent. As of now, ONCT has a P/S, P/E and, P/B values of 42.54, 0, and 9.41 respectively. Its P/Cash is valued at 0.
The stock SMA50 is now at 179.59 percent. In looking, the SMA 200 we see that the stock has seen a 101.84 percent. The Companys net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Looking into the profitability ratios of ONCT stock, an investor will find its ROE, ROA, ROI standing at -147.3 percent, -92.6 percent and, -231.5 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 58.31 percent volatile for the week and 18.54 percent for the month.
Gross / Operating Margins of ONCT:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price informs the investors, a stock survey at which a trader is willing to buy or sell a stock. At which a trader projects that a buyer will buy a product. The company Oncternal Therapeutics, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Oncternal Therapeutics, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 260.39 percent, resulting in a performance for the month at 195.21 percent.
Therefore, the stated figure displays a quarterly performance of 90.72 percent, bringing six-month performance to 116.8 percent and year to date performance of 40.51 percent. As of now, Oncternal Therapeutics, Inc. has a P/S, P/E and, P/B values of 42.54, 0, and 9.41 respectively. Its P/Cash is valued at 0.
Earnings per Share Details of Oncternal Therapeutics, Inc.:
The EPS of ONCT is strolling at -1.24, measuring its EPS growth this year at 64 percent. As a result, the company has an EPS growth of 30.3 percent for the approaching year.
EPS growth is an important number as it gives a suggestion of the future prospects of a company. It is usually expressed as a percentage and is then referred to as the EPS growth rate. Growth in EPS is an important measure of administration performance because it shows how much money the company is making for its investors or shareholders, not only because of changes in profit but also after all the effects of issuance of new shares (this is especially important when the growth comes as a result of acquisition).
Given the importance of identifying companies that will ensure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.